Peroxisome Proliferator Activated Receptor α Ligands as Anticancer Drugs Targeting Mitochondrial Metabolism

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 3, 2013-03 ,pp. : 342-356

Bentham Science Publishers

Access to resources Recommend Favorite

Dose calculation of anticancer drugs

By Gao Bo   Klumpen Heinz-Josef   Gurney Howard  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 10, 2008-10 ,pp. : 1307-1319

Informa Healthcare

Access to resources Recommend Favorite

Bisphosphonates as anticancer drugs

By Mundy G.R.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2009-2015

Informa Healthcare

Access to resources Recommend Favorite

Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia

By Denny W.A.   Wilson W.R.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 12, 2000-12 ,pp. : 2889-2901

Informa Healthcare

Access to resources Recommend Favorite

Advances in the development of hybrid anticancer drugs

By Fortin Sébastien  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 8, 2013-11 ,pp. : 1029-1047

Informa Healthcare

Access to resources Recommend Favorite